Tarsus Pharmaceuticals In... (TARS)
NASDAQ: TARS
· Real-Time Price · USD
53.52
-0.62 (-1.15%)
At close: Aug 15, 2025, 10:18 AM
-1.15% (1D)
| Bid | 53.46 |
| Market Cap | 2.26B |
| Revenue (ttm) | 295.52M |
| Net Income (ttm) | -91.99M |
| EPS (ttm) | -2.29 |
| PE Ratio (ttm) | -23.37 |
| Forward PE | 40.9 |
| Analyst | Buy |
| Ask | 53.58 |
| Volume | 85,282 |
| Avg. Volume (20D) | 606,832 |
| Open | 54.14 |
| Previous Close | 54.14 |
| Day's Range | 53.21 - 54.65 |
| 52-Week Range | 24.95 - 57.28 |
| Beta | 0.79 |
About TARS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TARS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TARS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Tarsus Pharmaceuticals has released their quartely earnings
on Aug 6, 2025:
Next Earnings Release
Tarsus Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-5.84%
Tarsus Pharmaceuticals shares are trading lower fo...
Unlock content with
Pro Subscription
5 months ago
-9.33%
Shares of Tarsus Pharmaceuticals are trading lower. The company reported Q4 financial results.
